SE446727B - Substituerade morfolinderivat och farmaceutisk komposition derav - Google Patents
Substituerade morfolinderivat och farmaceutisk komposition deravInfo
- Publication number
- SE446727B SE446727B SE7900498A SE7900498A SE446727B SE 446727 B SE446727 B SE 446727B SE 7900498 A SE7900498 A SE 7900498A SE 7900498 A SE7900498 A SE 7900498A SE 446727 B SE446727 B SE 446727B
- Authority
- SE
- Sweden
- Prior art keywords
- phenoxy
- benzyl
- morpholine
- methoxy
- ethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/32—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups bound to acyclic carbon atoms and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/16—Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
- C07D265/33—Two oxygen atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1944978A IT1093255B (it) | 1978-01-20 | 1978-01-20 | Derivati fenossialcanolaminici |
IT1945078A IT1111676B (it) | 1978-01-20 | 1978-01-20 | Derivati della 2-fenossimetil-morfolina |
IT3053478A IT1160302B (it) | 1978-12-05 | 1978-12-05 | Derivati della 2-fenossimentil-morfolina |
IT30535/78A IT1101724B (it) | 1978-12-05 | 1978-12-05 | Derivati morfolinici e fenossiprofanolaminici e procedimento per la loro preparazione |
IT3053378A IT1160301B (it) | 1978-12-05 | 1978-12-05 | Derivati fenossialcanolaminici |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7900498L SE7900498L (sv) | 1979-07-21 |
SE446727B true SE446727B (sv) | 1986-10-06 |
Family
ID=27517788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7900498A SE446727B (sv) | 1978-01-20 | 1979-01-19 | Substituerade morfolinderivat och farmaceutisk komposition derav |
Country Status (24)
Country | Link |
---|---|
US (2) | US4229449A (de) |
JP (1) | JPS54148739A (de) |
AT (1) | AT371813B (de) |
AU (1) | AU525954B2 (de) |
BG (1) | BG61056B2 (de) |
CA (1) | CA1128942A (de) |
CH (1) | CH650245A5 (de) |
CS (1) | CS413391A3 (de) |
CY (1) | CY1172A (de) |
DE (2) | DE19875005I2 (de) |
DK (1) | DK156565C (de) |
FI (1) | FI71135C (de) |
FR (2) | FR2442839A1 (de) |
GB (1) | GB2014981B (de) |
HK (1) | HK5783A (de) |
IE (1) | IE47727B1 (de) |
IL (1) | IL56369A (de) |
KE (1) | KE3243A (de) |
MY (1) | MY8400018A (de) |
NO (1) | NO146953C (de) |
NZ (1) | NZ189418A (de) |
SE (1) | SE446727B (de) |
SI (1) | SI7910096A8 (de) |
YU (1) | YU42094B (de) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4226523A (en) * | 1978-11-17 | 1980-10-07 | Energy Conversion Devices, Inc. | Imaging device |
GB8419683D0 (en) * | 1984-08-02 | 1984-09-05 | Erba Farmitalia | 3-substituted derivatives of 1-amino-2-hydroxy-propane |
GB2162517B (en) * | 1984-08-01 | 1988-04-27 | Erba Farmitalia | Process for the preparation of 3-substituted derivatives of 1-amino-2-hydroxy-propane |
DE3546929B4 (de) * | 1984-08-02 | 2006-02-09 | Pharmacia Italia S.P.A. | 1,2-substituierte Derivate von 3-Phenoxy-3-Phenylpropan |
GB2167407B (en) * | 1984-11-22 | 1988-05-11 | Erba Farmitalia | Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof |
GB8823405D0 (en) * | 1988-10-05 | 1988-11-09 | Erba Carlo Spa | Aryloxy-arythio-heteraryloxy-heteroarylthio-alkenylene derivatives of amines |
FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
JP2001517628A (ja) * | 1997-09-23 | 2001-10-09 | イーライ・リリー・アンド・カンパニー | 注意欠陥/多動障害の治療法 |
UA56257C2 (uk) * | 1997-09-23 | 2003-05-15 | Елі Ліллі Енд Компані | Спосіб лікування неадекватної визивної поведінки |
AU756373B2 (en) | 1998-04-09 | 2003-01-09 | Pharmacia & Upjohn Company | New treatments for nervous disorders |
US6586427B2 (en) * | 1998-04-09 | 2003-07-01 | Pharmacia & Upjohn Company | Treatments for nervous disorders |
IT1305322B1 (it) | 1998-04-23 | 2001-05-04 | Pharmacia & Upjohn Spa | Uso di reboxetina per il trattamento di disturbi nervosi |
US6500827B2 (en) * | 1998-05-08 | 2002-12-31 | Pharmacia & Upjohn Company | Drug combinations |
SI1140788T1 (en) * | 1998-12-29 | 2004-08-31 | Pharmacia & Upjohn Company | Method for the preparation of aryl ethers |
EP1459749B1 (de) * | 1999-07-01 | 2005-10-05 | Pharmacia & Upjohn Company LLC | (S,S)-Reboxetin zur Behandlung von Inkontinenz |
AU2005220235B2 (en) * | 1999-07-01 | 2007-05-10 | Pharmacia & Upjohn Company | Selective norepinephrine reuptake inhibitors and methods of using the same |
ES2242175T3 (es) * | 1999-07-01 | 2005-11-01 | PHARMACIA & UPJOHN COMPANY LLC | (s,s)-reboxetina para tratar la fibromialgia y otros trastornos somatoformes. |
CO5210862A1 (es) | 1999-09-15 | 2002-10-30 | Alza Corp | Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia |
AU2002213830A1 (en) * | 2000-10-31 | 2002-05-15 | Head Explorer A/S | The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache |
US20040034106A1 (en) * | 2001-11-06 | 2004-02-19 | Read Holly Ann | Treatment of anxiety disorders |
EP1455770B1 (de) * | 2001-11-30 | 2007-06-20 | Eli Lilly And Company | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks |
EP1494664A2 (de) * | 2002-04-18 | 2005-01-12 | Pharmacia Corporation | Kombinationen aus cox-2-hemmer und anderen agenten zur behandlung von morbus parkinsonian |
WO2004016272A1 (en) * | 2002-08-14 | 2004-02-26 | Pharmacia & Upjohn Company Llc | Use of reboxetine for the treatment of hot flashes |
US20040220153A1 (en) * | 2002-09-24 | 2004-11-04 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
US20040229849A1 (en) * | 2002-09-24 | 2004-11-18 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
US7345096B2 (en) * | 2002-10-15 | 2008-03-18 | Wyeth | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
US20040152710A1 (en) * | 2002-10-15 | 2004-08-05 | Deecher Darlene Coleman | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
EP1587782A1 (de) * | 2002-11-05 | 2005-10-26 | Eli Lilly and Company | 3-aryloxy/thio-3-substituierte propanamine und deren verwendung zur inhibierung der wiederaufnahme von serotonin und norepinephrine |
MY143244A (en) | 2002-11-26 | 2011-04-15 | Smithkline Beecham Corp | Calcilytic compounds |
US20040204411A1 (en) * | 2002-12-17 | 2004-10-14 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
CA2522666A1 (en) * | 2003-04-18 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Combination therapies for chronic obstructive pulmonary disease (copd) |
US20060100290A1 (en) * | 2003-07-28 | 2006-05-11 | Dunaway Leslie J | Treatment of allergic rhinitis and asthma |
KR20060087560A (ko) * | 2003-09-12 | 2006-08-02 | 워너-램버트 캄파니 엘엘씨 | 알파-2-델타 리간드 및 ssri 및/또는 snri를포함하는 우울증 및 불안 장애 치료용 조합물 |
DE602004024317D1 (de) | 2003-09-12 | 2010-01-07 | Pfizer | Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern |
US7419980B2 (en) * | 2003-10-14 | 2008-09-02 | Wyeth | Fused-aryl and heteroaryl derivatives and methods of their use |
US7550485B2 (en) * | 2003-10-14 | 2009-06-23 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
US20050130987A1 (en) * | 2003-10-14 | 2005-06-16 | Wyeth | Methods of treating vasomotor symptoms |
US7365076B2 (en) | 2003-10-14 | 2008-04-29 | Wyeth | Substituted aryl cycloalkanol derivatives and methods of their use |
US7524846B2 (en) * | 2003-10-14 | 2009-04-28 | Wyeth | Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
US7402698B2 (en) * | 2003-10-14 | 2008-07-22 | Wyeth | Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use |
US7531543B2 (en) * | 2003-10-14 | 2009-05-12 | Wyeth | Phenylpiperazine cycloalkanol derivatives and methods of their use |
US7491723B2 (en) * | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
ES2515092T3 (es) | 2003-12-11 | 2014-10-29 | Sunovion Pharmaceuticals Inc. | Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión |
WO2005082869A1 (en) * | 2004-02-20 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Method for the preparation of aryl ethers |
EP1730094A1 (de) * | 2004-02-20 | 2006-12-13 | Pharmacia & Upjohn Company LLC | Verfahren zur herstellung von arylethern |
US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
US7414052B2 (en) * | 2004-03-30 | 2008-08-19 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
AP2006003771A0 (en) * | 2004-04-30 | 2006-10-31 | Warner Lambert Co | Substituted morpholine compounds for the treatmentof central nervous system disorders |
GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
US7368477B2 (en) * | 2005-04-22 | 2008-05-06 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof |
CA2604916A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
CA2614289A1 (en) | 2005-07-08 | 2007-01-18 | Braincells, Inc. | Methods for identifying agents and conditions that modulate neurogenesis |
EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
EP1940389A2 (de) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation von neurogenese durch pde-hemmung |
WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007231011A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | New therapeutic combinations for the treatment of depression |
US20080020387A1 (en) * | 2006-03-31 | 2008-01-24 | Lawrence Donald G | Biomarker-optimized adhd treatment |
CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP2026813A2 (de) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5-ht-rezeptor-vermittelte neurogenese |
WO2008019431A1 (en) * | 2006-08-14 | 2008-02-21 | Brc Operations Pty Limited | Method and compositions for simultaneously regulating memory and mood |
EP2068872A1 (de) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Kombinationen mit einem 4-acylaminopyridin-derivat |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CA2663984C (en) | 2006-10-18 | 2012-02-21 | Pfizer Products Inc. | Biaryl ether urea compounds |
WO2008122019A1 (en) * | 2007-04-02 | 2008-10-09 | Cypress Biosciences, Inc. | Improving the tolerability of both mirtazapine and reboxetine by using them in combination |
CN101613347B (zh) * | 2008-06-23 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 胺类化合物及其医药用途 |
WO2010011811A2 (en) * | 2008-07-24 | 2010-01-28 | Theravance, Inc. | 3-(phenoxyphenylmethyl)pyrrolidine compounds |
US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
US8247433B2 (en) | 2008-11-14 | 2012-08-21 | Theravance, Inc. | Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US20100267743A1 (en) * | 2009-04-15 | 2010-10-21 | Stangeland Eric L | 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds |
CN105254552A (zh) * | 2009-07-13 | 2016-01-20 | 施万生物制药研发Ip有限责任公司 | 3-苯氧基甲基吡咯烷化合物 |
WO2011011231A1 (en) | 2009-07-21 | 2011-01-27 | Theravance, Inc. | 3-phenoxymethylpyrrolidine compounds |
US8778949B2 (en) | 2010-01-11 | 2014-07-15 | Theravance Biopharma R&D Ip, Llc | 1-(2-phenoxymethylphenyl)piperazine compounds |
ES2543064T3 (es) * | 2010-03-22 | 2015-08-14 | Theravance Biopharma R&D Ip, Llc | Compuestos de 1-(2-fenoximetilheteroaril)piperidina y piperazina |
WO2012051103A1 (en) | 2010-10-11 | 2012-04-19 | Theravance, Inc. | Serotonin reuptake inhibitors |
US8501964B2 (en) | 2010-12-03 | 2013-08-06 | Theravance, Inc. | Serotonin reuptake inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1138405A (en) * | 1966-12-28 | 1969-01-01 | Ici Ltd | Morpholine derivatives |
BE759013R (fr) * | 1969-11-17 | 1971-05-17 | Ici Ltd | Derives de la |
GB1382526A (en) * | 1972-08-11 | 1975-02-05 | Ici Ltd | Morpholine derivatives |
GB1412546A (en) * | 1973-08-08 | 1975-11-05 | Ici Ltd | Morpholine derivatives |
GB1427097A (en) * | 1973-10-18 | 1976-03-03 | Ici Ltd | Optically-active morpholine derivatives |
GB1469410A (en) * | 1973-12-17 | 1977-04-06 | Christiaens Sa A | Benzodioxole derivatives |
US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
CA1064927A (en) * | 1975-01-29 | 1979-10-23 | Yuji Kawashima | Process of producing 2-(indenyloxymethyl) morpholine derivatives |
GB1576216A (en) * | 1975-01-29 | 1980-10-01 | Yamanouchi Pharma Co Ltd | 2-(7-indenyloxymethyl)-morpholine derivatives and process of producing them |
CA1085841A (en) * | 1976-05-19 | 1980-09-16 | Jean-Marie Ferland | Aryloxy proplamines, their preparation and use thereof |
-
1979
- 1979-01-04 IL IL56369A patent/IL56369A/xx unknown
- 1979-01-08 US US06/001,604 patent/US4229449A/en not_active Expired - Lifetime
- 1979-01-11 GB GB7901130A patent/GB2014981B/en not_active Expired
- 1979-01-11 CY CY1172A patent/CY1172A/xx unknown
- 1979-01-12 DE DE1998175005 patent/DE19875005I2/de active Active
- 1979-01-12 DE DE2901032A patent/DE2901032C2/de not_active Expired - Lifetime
- 1979-01-12 AU AU43327/79A patent/AU525954B2/en not_active Expired
- 1979-01-17 SI SI7910096A patent/SI7910096A8/sl unknown
- 1979-01-17 YU YU96/79A patent/YU42094B/xx unknown
- 1979-01-17 NZ NZ189418A patent/NZ189418A/xx unknown
- 1979-01-18 DK DK022679A patent/DK156565C/da not_active IP Right Cessation
- 1979-01-19 CH CH582/79A patent/CH650245A5/de not_active IP Right Cessation
- 1979-01-19 AT AT0040679A patent/AT371813B/de not_active IP Right Cessation
- 1979-01-19 NO NO790205A patent/NO146953C/no unknown
- 1979-01-19 SE SE7900498A patent/SE446727B/sv active Protection Beyond IP Right Term
- 1979-01-19 CA CA319,931A patent/CA1128942A/en not_active Expired
- 1979-01-19 FR FR7901413A patent/FR2442839A1/fr active Granted
- 1979-01-19 FI FI790177A patent/FI71135C/fi not_active IP Right Cessation
- 1979-01-20 JP JP449479A patent/JPS54148739A/ja active Granted
- 1979-01-30 IE IE107/79A patent/IE47727B1/en active Protection Beyond IP Right Term
- 1979-09-11 FR FR7922678A patent/FR2430412B1/fr not_active Expired
-
1980
- 1980-06-20 US US06/161,509 patent/US4271160A/en not_active Expired - Lifetime
-
1982
- 1982-10-25 KE KE3243A patent/KE3243A/xx unknown
-
1983
- 1983-02-08 HK HK57/83A patent/HK5783A/xx not_active IP Right Cessation
-
1984
- 1984-12-31 MY MY8418A patent/MY8400018A/xx unknown
-
1991
- 1991-12-30 CS CS914133A patent/CS413391A3/cs unknown
-
1994
- 1994-02-22 BG BG098513A patent/BG61056B2/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE446727B (sv) | Substituerade morfolinderivat och farmaceutisk komposition derav | |
CA1341024C (en) | Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1, 2-diamine derivatives | |
NO327535B1 (no) | Produkter av amidinderivater samt anvendelse derav og medikament og farmasoytisk preparat | |
NO147950B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser | |
NO170973B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridinetanolaminderivater | |
DK147068B (da) | Analogifremgangsmaade til fremstilling af 1-naphthylmethyl-cinnamyl-aminderivater | |
ITMI20010042A1 (it) | Composti di eteri e di ammidi e loro preparazione come antidiabetici | |
NO178263B (no) | Nye benzomorfaner og deres anvendelse som legemiddel | |
WO2008081477A1 (en) | 3-aryloxy 3-substituted propanamines | |
JPH04210944A (ja) | アミノアルコキシ芳香族化合物 | |
NZ502128A (en) | Benzothiophene compounds and their use in treating neurological disorders | |
US20100210663A1 (en) | Hybrid 2-Aminotetralin and Aryl-Substituted Piperazine Compounds and their Use in Altering CNS Activity | |
AU629258B2 (en) | Aryloxy-, arylthio-, heteroaryloxy-, heteroarylthio- alkenylene derivatives of amines | |
NZ227565A (en) | Pyrazol- and indazol- pyridine amines and pharmaceutical compositions | |
US3965181A (en) | Tricyclic pharmacological agents, intermediates and methods of making | |
DK153547B (da) | Analogifremgangsmaade til fremstilling af aminoalkoxypyrazoler eller salte deraf | |
Yous et al. | Synthesis of the Naphthalenic Bioisostere of Indorenate. Synthese des Naphthalin‐Bioisosters von Indorenat | |
Perrone et al. | Monophenolic 2-amino-1-indanone and 2-amino-1-tetralone derivatives: synthesis and assessment of dopaminergic activity | |
US3951987A (en) | Tetrahydropyridine derivatives | |
US4772719A (en) | Process for the preparation of 3,5-disubstituted isoxazoles | |
BE873596A (fr) | Propanolamines et morpholines substituees et procede de preparation. | |
NO174098B (no) | Analogifremgangsmaate for fremstilling av aryloksy- og heteroaryloksyalkenylenderivater av aminer | |
SK286076B6 (sk) | Inhibítory biosyntézy cholesterolu a ergosterolu,spôsob ich prípravy a použitie | |
Zhao et al. | A PRACTICAL SYNTHESIS OF 4-ACETYL-2, 3, 4, 5-TETRAHYDRO-1 H-1, 4-BENZODIAZEPINE | |
NZ616676A (en) | Benzo [b] [1,4] oxazin derivatives as calcium sensing receptor modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7900498-2 Format of ref document f/p: F |
|
SPCF | Application for supplementary protection certificate filed |
Free format text: 9890011, 971030 |
|
NUG | Patent has lapsed |
Ref document number: 7900498-2 Format of ref document f/p: F |
|
SPCG | Supplementary protection certificate granted |
Free format text: 9890011, 971030, EXPIRES: 20040119 |